U18FD006993
Cooperative Agreement
Overview
Grant Description
Assessment of zoonotic risk of emerging infections in companion animals.
Awardee
Funding Goals
TO ASSIST INSTITUTIONS AND ORGANIZATIONS, TO ESTABLISH, EXPAND, AND IMPROVE RESEARCH, DEMONSTRATION, EDUCATION AND INFORMATION DISSEMINATION ACTIVITIES, ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), BIOLOGICS, BLOOD AND BLOOD PRODUCTS, THERAPEUTICS, VACCINES AND ALLERGENIC PROJECTS, DRUG HAZARDS, HUMAN AND VETERINARY DRUGS, CLINICAL TRIALS ON DRUGS AND DEVICES FOR ORPHAN PRODUCTS DEVELOPMENT, NUTRITION, SANITATION AND MICROBIOLOGICAL HAZARDS, MEDICAL DEVICES AND DIAGNOSTIC PRODUCTS, RADIATION EMITTING DEVICES AND MATERIALS, FOOD SAFETY AND FOOD ADDITIVES. THESE PROGRAMS ARE SUPPORTED DIRECTLY OR INDIRECTLY BY THE FOLLOWING CENTERS AND OFFICES: CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), CENTER FOR DEVICES AND RADIOLOGICAL HEALTH (CDRH), CENTER FOR VETERINARY MEDICINE (CVM), CENTER FOR FOOD SAFETY AND APPLIED NUTRITION (CFSAN), NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR), THE OFFICE OF ORPHAN PRODUCTS DEVELOPMENT (OPD), THE CENTER FOR TOBACCO PRODUCTS (CTP), AND OFFICE OF REGULATORY AFFAIRS (ORA), AND THE OFFICE OF THE COMMISSIONER (OC). SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAMS: TO STIMULATE TECHNOLOGICAL INNOVATION, TO ENCOURAGE THE ROLE OF SMALL BUSINESS TO MEET FEDERAL RESEARCH AND DEVELOPMENT NEEDS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION BY MINORITY AND DISADVANTAGED PERSONS IN TECHNOLOGICAL INNOVATION. FUNDING SUPPORT FOR SCIENTIFIC CONFERENCES THAT ARE RELEVANT TO THE FDA SCIENTIFIC MISSION AND PUBLIC HEALTH ARE ALSO AVAILABLE.
Grant Program (CFDA)
Awarding Agency
Funding Agency
Place of Performance
Ithaca,
New York
14853
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 682% from $125,600 to $982,655.
Cornell University was awarded
Assessment of Zoonotic Risk of Emerging Infections in Companion Animals
Cooperative Agreement U18FD006993
worth $982,655
from Food and Drug Administration in September 2020 with work to be completed primarily in Ithaca New York United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.103 Food and Drug Administration Research.
The Cooperative Agreement was awarded through grant opportunity Vet-LIRN Network Capacity-Building Projects.
Status
(Complete)
Last Modified 2/6/26
Period of Performance
9/15/20
Start Date
8/31/25
End Date
Funding Split
$982.7K
Federal Obligation
$0.0
Non-Federal Obligation
$982.7K
Total Obligated
Activity Timeline
Transaction History
Modifications to U18FD006993
Additional Detail
Award ID FAIN
U18FD006993
SAI Number
U18FD006993-759668432
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75FDA1 FDA Office of Acquisitions and Grants Services
Funding Office
75DJJ0 FDA OFFICE OF FOODS AND VETERINARY MEDICINE
Awardee UEI
G56PUALJ3KT5
Awardee CAGE
4B578
Performance District
NY-19
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) | Consumer and occupational health and safety | Grants, subsidies, and contributions (41.0) | $551,187 | 100% |
Modified: 2/6/26